Office of the Director, National Institutes of Health; Notice of Meeting, 14391 [2015-06267]

Download as PDF Federal Register / Vol. 80, No. 53 / Thursday, March 19, 2015 / Notices Dated: March 13, 2015. David Clary, Program Analyst, Office of Federal Advisory Committee Policy. [FR Doc. 2015–06270 Filed 3–18–15; 8:45 am] BILLING CODE 4140–01–P DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health Office of the Director, National Institutes of Health; Notice of Meeting Rmajette on DSK2VPTVN1PROD with NOTICES Pursuant to section 10(a) of the Federal Advisory Committee Act, as amended (5 U.S.C. App.), notice is hereby given of a meeting of the Advisory Committee on Research on Women’s Health. The meeting will be open to the public, with attendance limited to space available. Individuals who plan to attend and need special assistance, such as sign language interpretation or other reasonable accommodations, should notify the Contact Person listed below in advance of the meeting. Name of Committee: Advisory Committee on Research on Women’s Health. Date: April 10, 2014. Time: 9:00 a.m. to 4:00 p.m. Agenda: The Committee serves to advise and make recommendations to the Director, Office of Research on Women’s Health (ORWH) on a broad range of topics including, the current scope of research on women’s health and the influence of sex and gender on human health, efforts to understand the issues related to women in biomedical careers and their needs, and the current status of inclusion of women in clinical trials research. Place: National Institutes of Health, Building 35, Room 620/630, 35 Convent Drive, Bethesda, MD 20892. Contact Person: Susan E Maier, Ph.D., NIH/ OD, 6707 Democracy Blvd., Room 400, Bethesda, MD 20852, 301–435–1573, maiers@mail.nih.gov. Any interested person may file written comments for the public record by submitting their comments to the following email address ACRWHComments@ sp10mail.nih.gov. Written comments for the public record must not exceed two singlespaced, typed pages, using a 12-point typeface and 1 inch margins; it is preferred that the document be prepared in the MS Word® format. Only testimony submitted to this Web site and received in advance of the meeting are part of the official meeting record. Supplementary Information: A draft agenda for this meeting is posted at https://orwh.od.nih.gov/about/acrwh/ index.asp. The meeting will be live-video streamed at https://videocast.nih.gov/. Individuals who plan to attend the meeting in person should contact Faith Zeff at faith.zeff@nih.gov. Members of the media VerDate Sep<11>2014 15:18 Mar 18, 2015 Jkt 235001 will also need to register. In the interest of security, NIH has instituted stringent procedures for entrance onto the NIH campus. All visitor vehicles, including taxicabs, hotel, and airport shuttles will be inspected before being allowed on campus. Visitors will be asked to show one form of identification (for example, a governmentissued photo ID, driver’s license, or passport) and to state the purpose of their visit. (Catalogue of Federal Domestic Assistance Program Nos. 93.14, Intramural Research Training Award; 93.22, Clinical Research Loan Repayment Program for Individuals from Disadvantaged Backgrounds; 93.232, Loan Repayment Program for Research Generally; 93.39, Academic Research Enhancement Award; 93.936, NIH Acquired Immunodeficiency Syndrome Research Loan Repayment Program; 93.187, Undergraduate Scholarship Program for Individuals from Disadvantaged Backgrounds, National Institutes of Health, HHS) Dated: March 13, 2015. Carolyn Baum, Program Analyst, Office of Federal Advisory Committee Policy. [FR Doc. 2015–06267 Filed 3–18–15; 8:45 am] BILLING CODE 4140–01–P DEPARTMENT OF HEALTH AND HUMAN SERVICES Health Resources and Services Administration National Vaccine Injury Compensation Program; List of Petitions Received Health Resources and Services Administration, HHS. ACTION: Notice. AGENCY: The Health Resources and Services Administration (HRSA) is publishing this notice of petitions received under the National Vaccine Injury Compensation Program (the Program), as required by Section 2112(b)(2) of the Public Health Service (PHS) Act, as amended. While the Secretary of Health and Human Services is named as the respondent in all proceedings brought by the filing of petitions for compensation under the Program, the United States Court of Federal Claims is charged by statute with responsibility for considering and acting upon the petitions. FOR FURTHER INFORMATION CONTACT: For information about requirements for filing petitions, and the Program in general, contact the Clerk, United States Court of Federal Claims, 717 Madison Place NW., Washington, DC 20005, (202) 357–6400. For information on HRSA’s role in the Program, contact the Director, National Vaccine Injury Compensation Program, 5600 Fishers SUMMARY: PO 00000 Frm 00035 Fmt 4703 Sfmt 4703 14391 Lane, Room 11C–26, Rockville, MD 20857; (301) 443–6593. SUPPLEMENTARY INFORMATION: The Program provides a system of no-fault compensation for certain individuals who have been injured by specified childhood vaccines. Subtitle 2 of Title XXI of the PHS Act, 42 U.S.C. 300aa-10 et seq., provides that those seeking compensation are to file a petition with the U.S. Court of Federal Claims and to serve a copy of the petition on the Secretary of Health and Human Services, who is named as the respondent in each proceeding. The Secretary has delegated this responsibility under the Program to HRSA. The Court is directed by statute to appoint special masters who take evidence, conduct hearings as appropriate, and make initial decisions as to eligibility for, and amount of, compensation. A petition may be filed with respect to injuries, disabilities, illnesses, conditions, and deaths resulting from vaccines described in the Vaccine Injury Table (the Table) set forth at Section 2114 of the PHS Act or as set forth at 42 CFR 100.3, as applicable. This Table lists for each covered childhood vaccine the conditions that may lead to compensation and, for each condition, the time period for occurrence of the first symptom or manifestation of onset or of significant aggravation after vaccine administration. Compensation may also be awarded for conditions not listed in the Table and for conditions that are manifested outside the time periods specified in the Table, but only if the petitioner shows that the condition was caused by one of the listed vaccines. Section 2112(b)(2) of the PHS Act, 42 U.S.C. 300aa-12(b)(2), requires that ‘‘[w]ithin 30 days after the Secretary receives service of any petition filed under section 2111 the Secretary shall publish notice of such petition in the Federal Register.’’ Set forth below is a list of petitions received by HRSA on February 1, 2015, through February 28, 2015. This list provides the name of petitioner, city and state of vaccination (if unknown then city and state of person or attorney filing claim), and case number. In cases where the Court has redacted the name of a petitioner and/or the case number, the list reflects such redaction. Section 2112(b)(2) also provides that the special master ‘‘shall afford all interested persons an opportunity to submit relevant, written information’’ relating to the following: 1. The existence of evidence ‘‘that there is not a preponderance of the E:\FR\FM\19MRN1.SGM 19MRN1

Agencies

[Federal Register Volume 80, Number 53 (Thursday, March 19, 2015)]
[Notices]
[Page 14391]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2015-06267]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


Office of the Director, National Institutes of Health; Notice of 
Meeting

    Pursuant to section 10(a) of the Federal Advisory Committee Act, as 
amended (5 U.S.C. App.), notice is hereby given of a meeting of the 
Advisory Committee on Research on Women's Health.
    The meeting will be open to the public, with attendance limited to 
space available. Individuals who plan to attend and need special 
assistance, such as sign language interpretation or other reasonable 
accommodations, should notify the Contact Person listed below in 
advance of the meeting.

    Name of Committee: Advisory Committee on Research on Women's 
Health.
    Date: April 10, 2014.
    Time: 9:00 a.m. to 4:00 p.m.
    Agenda: The Committee serves to advise and make recommendations 
to the Director, Office of Research on Women's Health (ORWH) on a 
broad range of topics including, the current scope of research on 
women's health and the influence of sex and gender on human health, 
efforts to understand the issues related to women in biomedical 
careers and their needs, and the current status of inclusion of 
women in clinical trials research.
    Place: National Institutes of Health, Building 35, Room 620/630, 
35 Convent Drive, Bethesda, MD 20892.
    Contact Person: Susan E Maier, Ph.D., NIH/OD, 6707 Democracy 
Blvd., Room 400, Bethesda, MD 20852, 301-435-1573, 
maiers@mail.nih.gov.
    Any interested person may file written comments for the public 
record by submitting their comments to the following email address 
ACRWHComments@sp10mail.nih.gov. Written comments for the public 
record must not exceed two single-spaced, typed pages, using a 12-
point typeface and 1 inch margins; it is preferred that the document 
be prepared in the MS Word[supreg] format. Only testimony submitted 
to this Web site and received in advance of the meeting are part of 
the official meeting record.
    Supplementary Information: A draft agenda for this meeting is 
posted at https://orwh.od.nih.gov/about/acrwh/index.asp. The meeting 
will be live-video streamed at https://videocast.nih.gov/.
    Individuals who plan to attend the meeting in person should 
contact Faith Zeff at faith.zeff@nih.gov. Members of the media will 
also need to register. In the interest of security, NIH has 
instituted stringent procedures for entrance onto the NIH campus. 
All visitor vehicles, including taxicabs, hotel, and airport 
shuttles will be inspected before being allowed on campus. Visitors 
will be asked to show one form of identification (for example, a 
government-issued photo ID, driver's license, or passport) and to 
state the purpose of their visit.

(Catalogue of Federal Domestic Assistance Program Nos. 93.14, 
Intramural Research Training Award; 93.22, Clinical Research Loan 
Repayment Program for Individuals from Disadvantaged Backgrounds; 
93.232, Loan Repayment Program for Research Generally; 93.39, 
Academic Research Enhancement Award; 93.936, NIH Acquired 
Immunodeficiency Syndrome Research Loan Repayment Program; 93.187, 
Undergraduate Scholarship Program for Individuals from Disadvantaged 
Backgrounds, National Institutes of Health, HHS)

    Dated: March 13, 2015.
Carolyn Baum,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2015-06267 Filed 3-18-15; 8:45 am]
 BILLING CODE 4140-01-P

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.